Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYCLOOXYGENASE-2 INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 135 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hochberg, MC; Dougados, M
      Pharmacological therapy of osteoarthritis

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    2. Bazzoli, F; De Luca, L; Graham, DY
      Helicobacter pylori infection and the use of NSAIDs

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    3. Hawkey, CJ
      COX-1 and COX-2 inhibitors

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    4. Giercksky, KE
      COX-2 inhibition and prevention of cancer

      BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
    5. Kistler, T; Ambuhl, PM
      Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion

      SWISS MEDICAL WEEKLY
    6. Abdel-Hamid, M; Novotny, L; Hamza, H
      Liquid chromatographic-mass spectrometric determination of celecoxib in plasma using single-ion monitoring and its use in clinical pharmacokinetics

      JOURNAL OF CHROMATOGRAPHY B
    7. Mori, H; Niwa, K; Zheng, Q; Yamada, Y; Sakata, K; Yoshimi, N
      Cell proliferation in cancer prevention; effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    8. Jackson, CG
      Therapeutic potential of COX-2 inhibitors in arthritis

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    9. Oviedo, JA; Wolfe, MM
      Clinical potential of cyclo-oxygenase-2 inhibitors

      BIODRUGS
    10. May, N; Epstein, J; Osborne, B
      Selective COX-2 inhibitors: A review of their therapeutic potential and safety in dentistry

      ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
    11. McKenna, F; Weaver, A; Fiechtner, JJ; Bello, AE; Fort, JG
      COX-2 specific inhibitors in the management of osteoarthritis of the knee:A placebo-controlled, randomized, double-blind study

      JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
    12. Humar, B; D'Orazi, D; Albrecht, C; Bauerfeind, P; Muller, H; Dobbie, Z; Bendik, I
      Expression of putative anticancer targets in familial adenomatous polyposis and its association with the APC mutation status

      INTERNATIONAL JOURNAL OF ONCOLOGY
    13. Liu, SS; Yin, CS; Shi, YY; Cai, SX; Li, ZL
      MEDV-13 for QSAR studies on the COX-2 inhibition by indomethacin amides and esters

      CHINESE JOURNAL OF CHEMISTRY
    14. Chauret, N; Yergey, JA; Brideau, C; Friesen, RW; Mancini, J; Riendeau, D; Silva, J; Styhler, A; Trimble, LA; Nicoll-Griffith, DA
      In vitro metabolism considerations, including activity testing of metabolites, in the discovery and selection of the COX-2 inhibitor etoricoxib (MK-0663)

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    15. Wu, CL
      Regional anesthesia and anticoagulation

      JOURNAL OF CLINICAL ANESTHESIA
    16. Marotta, A; Tan, C; Gray, V; Malik, S; Gallinger, S; Sanghera, J; Dupuis, B; Owen, D; Dedhar, S; Salh, B
      Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis

      ONCOGENE
    17. Zhang, ZH; DuBois, RN
      Detection of differentially expressed genes in human colon carcinoma cellstreated with a selective COX-2 inhibitor

      ONCOGENE
    18. Toriyama-Baba, H; Iigo, M; Asamoto, M; Iwahori, Y; Park, CB; Han, BS; Takasuka, N; Kakizoe, T; Ishikawa, C; Yazawa, K; Araki, E; Tsuda, H
      Organotropic chemopreventive effects of n-3 unsaturated fatty acids in a rat multi-organ carcinogenesis model

      JAPANESE JOURNAL OF CANCER RESEARCH
    19. Grosch, S; Tegeder, I; Niederberger, E; Brautigam, L; Geisslinger, G
      COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib

      FASEB JOURNAL
    20. Lynch, PM
      COX-2 inhibition in clinical cancer prevention

      ONCOLOGY-NEW YORK
    21. Hawkey, CJ
      Gastrointestinal safety of COX-2 specific inhibitors

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    22. Bell, GM; Schnitzer, TJ
      Cox-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of pain in the elderly

      CLINICS IN GERIATRIC MEDICINE
    23. Hochberg, MC
      What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    24. Hawkey, CJ
      NSAIDs and COX-2 inhibitors: what can we learn from large outcomes trials?The gastroenterologist's perspective

      CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
    25. Gilroy, DW; Saunders, MA; Wu, KK
      COX-2 expression and cell cycle progression in human fibroblasts

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    26. Gianoukakis, AG; Cao, HJ; Jennings, TA; Smith, TJ
      Prostaglandin endoperoxide H synthase expression in human thyroid epithelial cells

      AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
    27. Yoshimi, N; Matsunaga, K; Katayama, M; Yamada, Y; Kuno, T; Qiao, Z; Hara, A; Yamahara, J; Mori, H
      The inhibitory effects of mangiferin, a naturally occurring glucosylxanthone, in bowel carcinogenesis of male F344 rats

      CANCER LETTERS
    28. McKenna, F; Borenstein, D; Wendt, H; Wallemark, C; Lefkowith, JB; Geis, GS
      Celecoxib versus diclofenac in the management of osteoarthritis of the knee - A placebo-controlled, randomised, double-blind comparison

      SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    29. Acevedo, E; Castaneda, O; Ugaz, M; Beaulieu, AD; Pons-Estel, B; Caeiro, F; Casas, N; Garza-Elizondo, M; Irazoque, F; Hinojosa, W; Gutierrez-Urena, S; Vandormael, K; Rodgers, DB; Laurenzi, M
      Tolerability profiles of rofecoxib (Vioxx (R)) and Arthrotoc (R) - A comparison of six weeks treatment in patients with osteoarthritis

      SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
    30. Dicker, AP; Williams, TL; Grant, DS
      Targeting angiogenic processes by combination rofecoxib and ionizing radiation

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    31. Arguedas, MR; Heudebert, GR; Wilcox, CM
      Surveillance colonoscopy or chemoprevention with COX-2 inhibitors in average-risk post-polypectomy patients: a decision analysis

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    32. Hawkey, CJ; Laine, L; Harper, SE; Quan, HUI; Bolognese, JA; Mortensen, E
      Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    33. Moodley, I; Hirsch, G
      Celecoxib - A rational alternative to NSAIDs

      SOUTH AFRICAN MEDICAL JOURNAL
    34. Moody, TW; Leyton, J; Zakowicz, H; Hida, T; Kang, Y; Jakowlew, S; You, L; Ozbun, L; Zia, H; Youngberg, J; Malkinson, A
      Indomethacin reduces lung adenoma number in A/J mice

      ANTICANCER RESEARCH
    35. Kobayashi, O; Miwa, H; Watanabe, S; Tsujii, M; Dubois, RN; Sato, N
      Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    36. Weaver, AL
      Rofecoxib: Clinical pharmacology and clinical experience

      CLINICAL THERAPEUTICS
    37. Williams, GW; Hubbard, RC; Yu, SS; Zhao, W; Geis, GS
      Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee

      CLINICAL THERAPEUTICS
    38. Gimbel, JS; Brugger, A; Zhao, W; Verburg, KM; Geis, GS
      Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen inthe treatment of pain after ambulatory orthopedic surgery in adults

      CLINICAL THERAPEUTICS
    39. DuBois, RN
      New paradigms for cancer prevention

      CARCINOGENESIS
    40. Li, Z; Shimada, Y; Kawabe, A; Sato, F; Maeda, M; Komoto, I; Hong, T; Ding, YZ; Kaganoi, J; Imamura, M
      Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor

      CARCINOGENESIS
    41. Hinrichs, R; Ritzkowsky, A; Hunzelmann, N; Krieg, T; Scharffetter-Kochanek, K
      Rofecoxib as an alternative in aspirin hypersensitivity

      ALLERGY
    42. Baillie, TA; Halpin, RA; Matuszewski, BK; Geer, LA; Chavez-Eng, CM; Dean, D; Braun, M; Doss, G; Jones, A; Marks, T; Melillo, D; Vyas, KP
      Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: Evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniques.

      DRUG METABOLISM AND DISPOSITION
    43. Myers, C; Koki, A; Pamukcu, R; Wechter, W; Padley, RJ
      Proapoptotic anti-inflammatory drugs

      UROLOGY
    44. Al-Waili, NSD
      Sublingual meloxicam for renal colic

      UROLOGIA INTERNATIONALIS
    45. Jakubikova, J; Duraj, J; Takacsova, X; Hunakova, L; Chorvath, B; Sedlak, J
      Non-steroidal anti-inflammatory agent ibuprofen-induced apoptosis, cell necrosis and cell cycle alterations in human leukemic cells in vitro

      NEOPLASMA
    46. Thompson, IM
      Pharmacologic agents in complementary medicine in prostatic disease

      DRUGS OF TODAY
    47. Sheng, HM; Shao, JY; Washington, MK; DuBois, RN
      Prostaglandin E-2 increases growth and motility of colorectal carcinoma cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    48. Vainio, H
      Is COX-2 inhibition a panacea for cancer prevention?

      INTERNATIONAL JOURNAL OF CANCER
    49. Li, M; Wu, XY; Xu, XC
      Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome C-dependent pathway in esophageal cancer cells

      INTERNATIONAL JOURNAL OF CANCER
    50. Shah, AA; Thjodleifsson, B; Murray, FE; Kay, E; Barry, M; Sigthorsson, G; Gudjonsson, H; Oddsson, E; Price, AB; Fitzgerald, DJ; Bjarnason, I
      Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen

      GUT
    51. Scott, DJ; Hull, MA; Cartwright, EJ; Lam, WK; Tisbury, A; Poulsom, R; Markham, AF; Bonifer, C; Coletta, PL
      Lack of inducible nitric oxide synthase promotes intestinal tumorigenesis in the ApcMin/+ mouse

      GASTROENTEROLOGY
    52. Wight, NJ; Gottesdiener, K; Garlick, NM; Atherton, CT; Novak, S; Gertz, BJ; Calder, NA; Cote, J; Wong, P; Dallob, A; Hawkey, CJ
      Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

      GASTROENTEROLOGY
    53. Kang, SS; Kim, JS; Son, KH; Kim, HP; Chang, HW
      Cyclooxygenase-2 inhibitory cerebrosides from Phytolaccae Radix

      CHEMICAL & PHARMACEUTICAL BULLETIN
    54. Bing, RJ
      Myocardial ischemia and infarction: growth of ideas

      CARDIOVASCULAR RESEARCH
    55. Bigler, J; Whitton, J; Lampe, JW; Fosdick, L; Bostick, RM; Potter, JD
      CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk

      CANCER RESEARCH
    56. Bakhle, YS
      COX-2 and cancer: a new approach to an old problem

      BRITISH JOURNAL OF PHARMACOLOGY
    57. Eli, Y; Przedecki, F; Levin, G; Kariv, N; Raz, A
      Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivo

      BIOCHEMICAL PHARMACOLOGY
    58. Shimamura, M; Hazato, T; Ashino, H; Yamamoto, Y; Iwasaki, E; Tobe, H; Yamamoto, K; Yamamoto, S
      Inhibition of angiogenesis by humulone, a bitter acid from beer hop

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    59. Tubaro, E; Belogi, L; Mezzadri, CM
      Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug

      ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    60. Bukowski, R; MacKay, L; Fittkow, C; Shi, L; Saade, GR; Garfield, RE
      Inhibition of cervical ripening by local application of cyclooxygenase 2 inhibitor

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    61. Moore, PA; Hersh, EV
      Celecoxib and rofecoxib - The role of COX-2 inhibitors in dental practice

      JOURNAL OF THE AMERICAN DENTAL ASSOCIATION
    62. Aggarwal, S; Taneja, N; Lin, L; Orringer, MB; Rehemtulla, A; Beer, DG
      Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involvesupregulation of Bax and translocation of mitochondrial cytochrome c independent of COX-2 expression

      NEOPLASIA
    63. Steinmeyer, J
      Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs

      ARTHRITIS RESEARCH
    64. Wollheim, FA
      Selective Cox-2 inhibition in man - therapeutic breakthrough or cosmetic advance?

      RHEUMATOLOGY
    65. Tive, L
      Celecoxib clinical profile

      RHEUMATOLOGY
    66. Chavez-Eng, CM; Constanzer, ML; Matuszewski, BK
      Determination of Rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection

      JOURNAL OF CHROMATOGRAPHY B
    67. Reddy, BS; Rao, CV
      Colon cancer - A role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs

      DRUGS & AGING
    68. Boyce, EG; Takiya, L
      Nonsteroidal anti-inflammatory drugs: Review of factors guiding formulary selection

      FORMULARY
    69. Reddy, BS
      Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    70. Creamer, P
      Osteoarthritis pain and its treatment

      CURRENT OPINION IN RHEUMATOLOGY
    71. Shureiqi, I; Reddy, P; Brenner, DE
      Chemoprevention: general perspective

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    72. Grob, M; Scheidegger, P; Wuthrich, B
      Allergic skin reaction to celecoxib

      DERMATOLOGY
    73. Smith, ML; Hawcroft, G; Hull, MA
      The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action

      EUROPEAN JOURNAL OF CANCER
    74. Gilroy, DW; Colville-Nash, PR
      New insights into the role of COX 2 in inflammation

      JOURNAL OF MOLECULAR MEDICINE-JMM
    75. van Ryn, J; Trummlitz, G; Pairet, M
      COX-2 selectivity and inflammatory processes

      CURRENT MEDICINAL CHEMISTRY
    76. Lee, MW; Kim, JH; Jeong, DW; Ahn, KH; Toh, SH; Surh, YJ
      Inhibition of cyclooxygenase-2 expression by diarylheptanoids from the bark of Alnus hirsuta var. sibirica

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    77. Ungar, A; Cristofari, C; Torrini, M; Di Serio, C; Cantini, C; Vallotti, B; La Cava, G; Castellani, S; Masotti, G
      Changes in renal autacoids in aged human hypertensives

      JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    78. Fournier, DB; Gordon, GB
      COX-2 and colon cancer: Potential targets for chemoprevention

      JOURNAL OF CELLULAR BIOCHEMISTRY
    79. Patrignani, P
      Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer

      TOXICOLOGY LETTERS

    80. Rofecoxib - Vioxx (R) - Antiarthritic - COX-2 inhibitor

      DRUGS OF THE FUTURE
    81. Turull, A; Queralt, J
      Effect of the COX-2 selective inhibitor L-745,337 on inflammation and organ prostaglandin E-2 (PGE(2)) levels in adjuvant arthritic rats

      INFLAMMATION
    82. Davies, NM; McLachlan, AJ; Day, RO; Williams, KM
      Clinical pharmacokinetics and pharmacodynamics of celecoxib - A selective cyclo-oxygenase-2 inhibitor

      CLINICAL PHARMACOKINETICS
    83. Marks, F; Muller-Decker, K; Furstenberger, C
      A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism

      TOXICOLOGY
    84. Ota, S; Bamba, H; Kato, A
      Colorectal cancer and non-steroidal anti-inflammatory drugs

      ACTA PHARMACOLOGICA SINICA
    85. Brown, WA; Farmer, KC; Skinner, SA; Malcontenti-Wilson, C; Misajon, A; O'Brien, PE
      5-aminosalicylic acid and olsalazine inhibit tumor growth in a rodent model of colorectal cancer

      DIGESTIVE DISEASES AND SCIENCES
    86. Tanaka, T; Kohno, H; Shimada, R; Kagami, S; Yamaguchi, F; Kataoka, S; Ariga, T; Murakami, A; Koshimizu, K; Ohigashi, H
      Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats

      CARCINOGENESIS
    87. Sasai, H; Masaki, M; Wakitani, K
      Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta 474) by a novel COX-2 inhibitor, JTE-522

      CARCINOGENESIS
    88. Tardieu, D; Jaeg, JP; Deloly, A; Corpet, DE; Cadet, J; Petit, CR
      The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats

      CARCINOGENESIS
    89. Tsutsumi, M; Kitada, H; Shiraiwa, K; Takahama, M; Tsujiuchi, T; Sakitani, H; Sasaki, Y; Murakawa, K; Yoshimoto, M; Konishi, Y
      Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats

      CARCINOGENESIS
    90. Kowaluk, EA; Lynch, KJ; Jarvis, MF
      Recent advances in development of novel analgesics

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
    91. Paulson, SK; Zhang, JY; Jessen, SM; Lawal, Y; Liu, NWK; Dudkowski, CM; Wang, YF; Chang, M; Yang, D; Findlay, JWA; Berge, MA; Markos, CS; Breau, AP; Hribar, JD; Yuan, J
      Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey

      XENOBIOTICA
    92. Giercksky, KE; Haglund, U; Rask-Madsen, J
      Selective inhibitors of COX-2 - Are they safe for the stomach?

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    93. Singla, AK; Chawla, M; Singh, A
      Nimesulide: Some pharmaceutical and pharmacological aspects - An update

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    94. Petrik, MBH; McEntee, MF; Chiu, CH; Whelan, J
      Antagonism of arachidonic acid is linked to the antitumorigenic effect of dietary eicosapentaenoic acid in Apc(Min/+) mice

      JOURNAL OF NUTRITION
    95. Whittle, BJR
      COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors

      GUT
    96. Ohd, JF; Wikstrom, K; Sjolander, A
      Leukotrienes induce cell-survival signaling in intestinal epithelial cells

      GASTROENTEROLOGY
    97. Hawkey, CJ
      Nonsteroidal anti-inflammatory drug gastropathy

      GASTROENTEROLOGY
    98. Zhang, ZH; DuBois, RN
      Par-4, a proapoptotic gene, is regulated by NSAIDs in human colon carcinoma cells

      GASTROENTEROLOGY
    99. Jackson, LM; Hawkey, CJ
      COX-2 selective nonsteroidal anti-inflammatory drugs - Do they really offer any advantages?

      DRUGS
    100. Schwartz, JI; Bugianesi, KJ; Ebel, DL; De Smet, M; Haesen, R; Larson, PJ; Ko, A; Verbesselt, R; Hunt, TL; Lins, R; Lens, S; Porras, AG; Dieck, J; Keymeulen, B; Gertz, BJ
      The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin

      CLINICAL PHARMACOLOGY & THERAPEUTICS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/02/20 alle ore 20:52:10